Skull base chondrosarcoma

Awad, Mohammed; Gogos, Andrew; Kaye, Andrew H.

doi:10.1016/j.jocn.2015.10.029

Cited by 51 publications

(39 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ten case reports on the application of the EEA for the surgical treatment of skull‐base chondrosarcomas were found . Out of a total of 12 patients, GTR was achieved in 5 cases.…”

Section: Clival Tumorsmentioning

confidence: 99%

ICAR: endoscopic skull‐base surgery

Wang

Zanation

Gardner

et al. 2019

Int Forum Allergy Rhinol

151

279

View full text Add to dashboard Cite

Background Endoscopic skull‐base surgery (ESBS) is employed in the management of diverse skull‐base pathologies. Paralleling the increased utilization of ESBS, the literature in this field has expanded rapidly. However, the rarity of these diseases, the inherent challenges of surgical studies, and the continued learning curve in ESBS have resulted in significant variability in the quality of the literature. To consolidate and critically appraise the available literature, experts in skull‐base surgery have produced the International Consensus Statement on Endoscopic Skull‐Base Surgery (ICAR:ESBS). Methods Using previously described methodology, topics spanning the breadth of ESBS were identified and assigned a literature review, evidence‐based review or evidence‐based review with recommendations format. Subsequently, each topic was written and then reviewed by skull‐base surgeons in both neurosurgery and otolaryngology. Following this iterative review process, the ICAR:ESBS document was synthesized and reviewed by all authors for consensus. Results The ICAR:ESBS document addresses the role of ESBS in primary cerebrospinal fluid (CSF) rhinorrhea, intradural tumors, benign skull‐base and orbital pathology, sinonasal malignancies, and clival lesions. Additionally, specific challenges in ESBS including endoscopic reconstruction and complication management were evaluated. Conclusion A critical review of the literature in ESBS demonstrates at least the equivalency of ESBS with alternative approaches in pathologies such as CSF rhinorrhea and pituitary adenoma as well as improved reconstructive techniques in reducing CSF leaks. Evidence‐based recommendations are limited in other pathologies and these significant knowledge gaps call upon the skull‐base community to embrace these opportunities and collaboratively address these shortcomings.

show abstract

“…Ten case reports on the application of the EEA for the surgical treatment of skull‐base chondrosarcomas were found . Out of a total of 12 patients, GTR was achieved in 5 cases.…”

Section: Clival Tumorsmentioning

confidence: 99%

ICAR: endoscopic skull‐base surgery

Wang

Zanation

Gardner

et al. 2019

Int Forum Allergy Rhinol

151

279

View full text Add to dashboard Cite

show abstract

“…This suggests that the tumor has certain characteristics in imaging, but because of the low incidence, imaging doctors lack of diagnostic experience, it is easy to misdiagnose; and if the tissue for pathology is not su cient, it is also easy to mislead the diagnosis of pathology. Although radiotherapy may play a supporting role in the treatment of skull base ChSa, surgery is the most effective method to eradicate or prolong the patient's life because the tumors' character which rarely metastasizes, shows expansive and invasive growth, and has clear borders [1,9,16].…”

Section: Discussionmentioning

confidence: 99%

Endoscopic surgical treatment with nasal cavity approach for chondrosarcoma of paranasal sinus and the skull base

Gao

Zhu

et al. 2020

Preprint

View full text Add to dashboard Cite

Background Chondrosarcoma(ChSa) is a rare malignant tumor. But it’s necessary to discuss the clinical characteristics and treatments for ChSa of paranasal sinus and the skull base.We aimed to Observe the effect of Endoscopic surgical treatment with nasal cavity approach for chondrosarcoma of paranasal sinus and the skull base Methods The clinical characteristics of chondrosarcoma of paranasal sinus and skull base in 10 patients (6 males and 4 females) from 2001 to 2017 were analyzed. They all underwent by endoscopic surgery. The patients’ age ranged from 18 to 47 years, with a median of 35 years. Clinical symptoms: stuffy, nose bleeding, runny, headache, diplopia, eye outreach limited, blurred vision and even blindness. Surgery methods：under nasal endoscopy, after the attachment sites of the tumors to normal tissues were confirmed, the tumors were peeled off along the clear boundary between the tumors and normal tissues, and the potential residual tumor tissues on bones were cleared by a drill. If internal carotid artery (ICA) were involved, flap would be used to protect it. Objectives Results All patients were treated with endoscopic surgery，followed up postoperatively for 24 to 108 months, with a median of 36 months. 8 of 10 patients were no recurrence,2 were alive with tumor. Conclusion Chondrosarcoma of paranasal sinus and skull base can be treated by nasal endoscopic surgery with good clinical results.

show abstract

“…character which rarely metastasizes, shows expansive and invasive growth, and has clear borders [1,9,16].…”

Section: Discussionmentioning

confidence: 99%

“…Chondrosarcoma(ChSa) is a rare malignant tumor composed of transformed chondrocytes and commonly occur within the axial or appendicular skeleton [1]. ChSa account for approximately 3 new cases per 10 6 population per year [2].…”

Section: Introductionmentioning

confidence: 99%

Endoscopic surgical treatment with nasal cavity approach for chondrosarcoma of paranasal sinus and the skull base

Gao

Zhu

et al. 2019

Preprint

View full text Add to dashboard Cite

Background Chondrosarcoma(ChSa) is a rare malignant tumor. But it’s necessary to discuss the clinical characteristics and treatments for ChSa of paranasal sinus and the skull base. Methods The clinical characteristics of ChSa of paranasal sinus and skull base in 10 patients (6 males and 4 females) from 2001 to 2017 were analyzed. They all underwent by endoscopic surgery . The patients’ age ranged from 18 to 47 years, with a median of 35 years. Clinical symptoms: stuffy, nose bleeding, runny, headache, diplopia, eye outreach limited, blurred vision and even blindness. Surgery methods：under nasal endoscopy, after the attachment sites of the tumors to normal tissues were confirmed, the tumors were peeled off along the clear boundary between the tumors and normal tissues, and the potential residual tumor tissues on bones were cleared by a drill. Results All patients were treated with endoscopic surgery，followed up postoperatively for 24 to 108 months, with a median of 36 months. 8 of 10 patients were no recurrence,2 were alive with tumor. Conclusion ChSa of paranasal sinus and skull base can be treated by nasal endoscopic surgery with good clinical results.

show abstract

Skull base chondrosarcoma

Cited by 51 publications

References 22 publications

ICAR: endoscopic skull‐base surgery

ICAR: endoscopic skull‐base surgery

Endoscopic surgical treatment with nasal cavity approach for chondrosarcoma of paranasal sinus and the skull base

Endoscopic surgical treatment with nasal cavity approach for chondrosarcoma of paranasal sinus and the skull base

Contact Info

Product

Resources

About